Physician profile
Kara E Grossman
NPI 1295501872
$1,102.40
in general payments reported to CMS, 2019-2025
11 companies · $693 in 2025
The $693 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $410 · 2025: $693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,102.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $234.17 | 2025 | Axonics, Ams 700 |
| Sumitomo Pharma America, INC. | $208.70 | 2024-2025 | Gemtesa, Orgovyx |
| Convatec INC. | $174.38 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $136.99 | 2024 | Bard Urinary Drainage Bag |
| Teleflex LLC | $134.61 | 2024 | Urolift |
| Urogen Pharma, INC. | $93.72 | 2024-2025 | |
| Tolmar, INC. | $35.64 | 2024 | |
| Baxter Healthcare | $26.95 | 2024 | Perclot |
| Progenics Pharmaceuticals, INC. | $26.15 | 2025 | |
| Abbvie INC. | $16.18 | 2025 | |
| Sun Pharmaceutical Industries INC. | $14.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara Grossman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.